ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Treatment Guidelines Updated for Ankylosing Spondylitis, Axial SpA
August 29, 2019In a special article published online in Arthritis Care & Research, the American College of Rheumatology, Spondylitis Association of America... -
Lilly Receives FDA Approval for Ankylosing Spondylitis Treatment
August 28, 2019This is the third indication for Taltz, first approved for moderate to severe plaque psoriasis. -
Novartis Begins Study Evaluating Higher Dose of Cosentyx for Ankylosing Spondylitis
December 11, 2017Novartis announced the initiation of the ASLeap trial in patients with ankylosing spondylitis , evaluating the effect of changing to a higher dose of Cosentyx in patients who do not achieve symptom remission after treatment with Cosentyx 150 mg for 16 we
Pharma Sources Insight January 2025
